Browsing by Author Arance, Ana

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)Citation
2017Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanomaLong, Georgina; Arance, Ana; Chiarion-Sileni, Vanna; Cowey, C. Lance; Dalle, S; Del Vecchio, M; et al, Various; Gogas, Helen; Mandala, Mario; Schenker, Michael; Weber, Jeffrey; Northern Clinical School: MedicineAdjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma, New England Journal of Medicine, vol.377, 19, 2017,pp 1824-1835
2017Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trialLong, Georgina; Arance, Ana; Chiarion-Sileni, Vanna; Davies, Michael; Del Vecchio, M; Flaherty, Keith; Grob, Jean-Jacques; Hogg, David; Huang, Yingjie; Lebbe, Celeste; Lesimple, Thierry; Márquez-Rodas, Ivan; Meyer, Nicolas; Mookerjee, Bijoyesh P; Mortier, Laurent; Moschos, S; Robert, Caroline; Saiag, Philippe; Thomas, Luc; Zhang, Ying; Northern Clinical School: MedicineDabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial, The Lancet Oncology, vol.18, 7, 2017,pp 863-873
2015Pembrolizumab versus ipilimumab in advanced melanomaCarlino, Matteo; Long, Georgina; Arance, Ana; Daud, Adil; et al, Various; Grob, Jean Jacques; Larkin, James; Lorigan, Paul; Lotem, Michal; McNeil, Catriona; Mortier, Laurent; Neyns, Bart; Robert, Caroline; Schachter, Jacob; Western Clinical School: Medicine (Westmead); Central Clinical School: The Sydney Cancer CentrePembrolizumab versus ipilimumab in advanced melanoma, The New England Journal of Medicine, vol.372, 26, 2015,pp 2521-2532
2017Phase I dose-escalation and -expansion study of the BRAF inhibitor encorafenib (LGX818) in metastatic BRAF-mutant melanomaCarlino, Matteo; Kefford, Richard (Rick); Arance, Ana; Delord, Jean-Pierre; et al, Various; Kudchakar, Ragini; Mahipal, Amit; McArthur, Grant A.; Nyakas, Marta; Robert, Caroline; Sullivan, Ryan; Yamada, Yasuhide; Westmead Clinical School: Medicine; Westmead Clinical School: MedicinePhase I dose-escalation and -expansion study of the BRAF inhibitor encorafenib (LGX818) in metastatic BRAF-mutant melanoma, Clinical Cancer Research, vol.23, 18, 2017,pp 5339-5348